Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dolby Laboratories Inc shares valued at $200 were purchased by YEAMAN KEVIN J on Jun 17 ’24. At $78.15 per share, YEAMAN KEVIN J acquired 3 shares. The insider’s holdings grew to 3 shares worth approximately $224.96999999999997 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, SHERMAN MARK ANDREW sold 2,283 shares, netting a total of over 181,772 in proceeds. Following the sale of shares at $79.62 each, the insider now holds 58,325 shares.
Before that, Rollins Emily had sold 1,000 shares from its account. In a trade valued at $80,880, the Director traded Dolby Laboratories Inc shares for $80.88 each. Upon closing the transaction, the insider’s holdings decreased to 1,000 shares, worth approximately $0.56 million.
As published in a research note from Barrington Research on June 03, 2024, Dolby Laboratories Inc [DLB] has been rated up from a Mkt perform to an Outperform and the price target has been revised to $100. Analysts at Barrington Research downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in mid November. As of May 24, 2022, Rosenblatt has initiated its “Buy” rating for DLB. Earlier on August 02, 2021, Barrington Research upgraded its rating. Their new recommendation was “an Outperform” for DLB stock which previously was a “a Mkt perform”.
Analyzing DLB Stock Performance
During the last five days, there has been a surge of approximately 3.18%. Over the course of the year, Dolby Laboratories Inc shares have dropped approximately -12.98%. Shares of the company reached a 52-week high of $86.37 on 01/24/24 and a 52-week low of $66.35 on 08/12/24. A 50-day SMA is recorded $73.16, while a 200-day SMA reached $79.76. Nevertheless, trading volume fell to 0.67 million shares from 0.28 million shares the previous day.
Support And Resistance Levels for Dolby Laboratories Inc (DLB)
According to the 24-hour chart, there is a support level at 74.21, which, if violated, would cause prices to drop to 73.43. In the upper region, resistance lies at 75.50. The next price resistance is at 76.02. RSI (Relative Strength Index) is 64.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.46, which suggests the price will increase in the coming days. Percent R is at 3.62%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
